ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 251 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2018. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,628,000 | +4.8% | 123,886 | +0.5% | 0.01% | +16.7% |
| Q2 2023 | $1,554,000 | -2.9% | 123,299 | +0.5% | 0.01% | -14.3% |
| Q1 2023 | $1,601,000 | -25.8% | 122,669 | +0.3% | 0.01% | -22.2% |
| Q4 2022 | $2,157,000 | -8.4% | 122,256 | -21.0% | 0.01% | -18.2% |
| Q3 2022 | $2,356,000 | +20.3% | 154,694 | +17.1% | 0.01% | +37.5% |
| Q2 2022 | $1,959,000 | -34.2% | 132,087 | -0.1% | 0.01% | -27.3% |
| Q1 2022 | $2,978,000 | +22.1% | 132,260 | +0.1% | 0.01% | +37.5% |
| Q4 2021 | $2,439,000 | +38.4% | 132,192 | +0.3% | 0.01% | +33.3% |
| Q3 2021 | $1,762,000 | -32.8% | 131,794 | -7.0% | 0.01% | -33.3% |
| Q2 2021 | $2,623,000 | +22.7% | 141,709 | -0.4% | 0.01% | +12.5% |
| Q1 2021 | $2,137,000 | +3.7% | 142,300 | -0.3% | 0.01% | -11.1% |
| Q4 2020 | $2,061,000 | +21.8% | 142,727 | -31.3% | 0.01% | 0.0% |
| Q3 2020 | $1,692,000 | +20.3% | 207,894 | +0.0% | 0.01% | +12.5% |
| Q2 2020 | $1,407,000 | -3.7% | 207,886 | +0.2% | 0.01% | -20.0% |
| Q1 2020 | $1,461,000 | -7.2% | 207,471 | +29.4% | 0.01% | +25.0% |
| Q4 2019 | $1,574,000 | -10.9% | 160,351 | -0.3% | 0.01% | -11.1% |
| Q3 2019 | $1,766,000 | +50.3% | 160,811 | +59.1% | 0.01% | +50.0% |
| Q2 2019 | $1,175,000 | -55.1% | 101,044 | -63.2% | 0.01% | -57.1% |
| Q1 2019 | $2,619,000 | +70.6% | 274,483 | +72.3% | 0.01% | +55.6% |
| Q4 2018 | $1,535,000 | +1361.9% | 159,284 | +2066.0% | 0.01% | +800.0% |
| Q3 2018 | $105,000 | +14.1% | 7,354 | -4.5% | 0.00% | – |
| Q2 2018 | $92,000 | -5.2% | 7,697 | -2.3% | 0.00% | -100.0% |
| Q1 2018 | $97,000 | -43.9% | 7,881 | -33.7% | 0.00% | 0.0% |
| Q4 2017 | $173,000 | +2.4% | 11,882 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $169,000 | -42.9% | 11,882 | -48.8% | 0.00% | 0.0% |
| Q2 2017 | $296,000 | -72.0% | 23,226 | -72.1% | 0.00% | -83.3% |
| Q1 2017 | $1,057,000 | +2.1% | 83,342 | -2.7% | 0.01% | 0.0% |
| Q4 2016 | $1,035,000 | -9.6% | 85,643 | -1.5% | 0.01% | -14.3% |
| Q3 2016 | $1,145,000 | +11.1% | 86,944 | +7.1% | 0.01% | 0.0% |
| Q2 2016 | $1,031,000 | -9.6% | 81,172 | -5.9% | 0.01% | 0.0% |
| Q1 2016 | $1,140,000 | -0.3% | 86,295 | +16.1% | 0.01% | 0.0% |
| Q4 2015 | $1,144,000 | +15.6% | 74,353 | -6.8% | 0.01% | +16.7% |
| Q3 2015 | $990,000 | -17.5% | 79,800 | -9.1% | 0.01% | -14.3% |
| Q2 2015 | $1,200,000 | +27.7% | 87,746 | +11.7% | 0.01% | +40.0% |
| Q1 2015 | $940,000 | +33.7% | 78,557 | +42.6% | 0.01% | +25.0% |
| Q4 2014 | $703,000 | +12.5% | 55,088 | +18.2% | 0.00% | 0.0% |
| Q3 2014 | $625,000 | -38.2% | 46,589 | -26.0% | 0.00% | -33.3% |
| Q2 2014 | $1,011,000 | -7.2% | 62,998 | +4.3% | 0.01% | 0.0% |
| Q1 2014 | $1,089,000 | -4.4% | 60,390 | -18.0% | 0.01% | 0.0% |
| Q4 2013 | $1,139,000 | +23.7% | 73,649 | +18.9% | 0.01% | +20.0% |
| Q3 2013 | $921,000 | +42.1% | 61,950 | +23.7% | 0.01% | +25.0% |
| Q2 2013 | $648,000 | – | 50,092 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
| EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
| Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
| KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
| Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
| Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |